Novocure
NVCR
#5712
Rank
A$1.96 B
Marketcap
Country
A$16.77
Share price
-4.48%
Change (1 day)
-2.79%
Change (1 year)
Categories

Earnings for Novocure (NVCR)

Earnings in 2026 (TTM): -A$0.14 Billion

According to Novocure 's latest financial reports the company's current earnings are A$0.72 Billion. In 2025 the company made an earning of -A$0.18 Billion, an increase over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novocure from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.14 Billion-26.38%
2025 -A$0.18 Billion-1.33%
2024 -A$0.18 Billion-35.88%
2023 -A$0.28 Billion139.99%
2022 -A$0.12 Billion61.43%
2021 -A$72.18 Million-235.99%
2020 A$53.07 M630.75%
2019 A$7.26 M-115.08%
2018 -A$48.17 Million-15.13%
2017 -A$56.75 Million-66.9%
2016 -A$0.18 Billion10.26%
2015 -A$0.16 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-A$3.69 Million-97.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-A$0.11 Billion-18.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-A$0.34 Billion 148.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-A$0.14 Billion 0.00% Jersey